Avantor VWR Now Offers CardioChek Plus and A1CNow+

WHITESTOWN, Ind., Oct. 4, 2023—PTS Diagnostics, a leading provider of rapid lipid, blood glucose and A1C testing devices has entered into an agreement with Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries. This partnership will deliver upon the growing customer need for fast, accurate, and portable blood testing devices.

Biopharma and life science companies who need to regularly test and re-test lipid, glucose and A1C can purchase CardioChek Plus and A1CNow+ test systems from VWR, Avantor’s channel brand. These solutions remove the burden of scheduling and rescheduling appointments for blood draws, and often provide a more comfortable experience for patients by requiring only a fingerstick blood sample. The devices also remove some of the hassles of storage and portability of testing equipment by being small, lightweight, and battery-powered, and by allowing room temperature storage of testing materials and control solutions.

“Through our partnership with Avantor, more clinical professionals will benefit from the efficiencies that CardioChek Plus and A1CNow+ test systems have been bringing to the healthcare industry for years. Our accurate, fast, and easy-to-use blood testing systems, combined with Avantor’s market reach, will allow both companies to fulfill their shared mission of meeting the changing needs of our customers,” said Steve Riendeau, Chief Commercial Officer of PTS Diagnostics.

The partnership with Avantor will expand the availability of PTS Diagnostics flagship products to Avantor’s customers in the point-of-care testing space and will position both companies to offer more flexible solutions for a changing life sciences marketplace.

About PTS Diagnostics
PTS Diagnostics provides innovative, superior quality, point-of-care solutions.  Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. Our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the life sciences and technology industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.

 

PTS Diagnostics Media Contact

Laurie Gutzwiller
Vice-President Global Marketing
317-860-8070
lgutzwiller@ptsdiagnostics.com

 

 

 

PTS Diagnostics and MedPro Healthcare Sales Solutions Enter Into Partnership

PTS Diagnostics and MedPro Healthcare Sales Solutions Enter Into Partnership

Effective immediately, augments existing accomplished sales force

WHITESTOWN, Ind. (April 1, 2020) – PTS Diagnostics, a U.S.-based manufacturer of point-of- care medical testing devices announced today that they are partnering with MedPro Healthcare Sales Solutions, a leading healthcare contract sales organization.

The partnership adds positions to the existing PTS Diagnostics sales force. These new representatives will be strategically staggered throughout the country and managed by PTS Diagnostics directors and senior sales managers. Together they’ll be responsible for expanding the footprint of the CardioChek® and A1CNow® product lines.

“MedPro’s support is crucial to achieving our core mission of closing gaps in care and potentially improving the outcomes of individuals with chronic conditions such as diabetes and cardiovascular disease,” said Cliffe Allen, VP of U.S. Sales of PTS Diagnostics. “Their knowledge regarding point-of-care testing combined with exceptional distribution relationships positions us for ongoing success in numerous vertical markets.”

MedPro was founded in 2006 and has grown into a leading sales force that’s trusted by manufacturers and distributors of all sizes. Their team’s connections span across a wide spectrum of healthcare delivery models, allowing for a streamlined sales cycle.

PTS Diagnostics’ solutions represent the first and only point-of-care lipid, glucose, and HbA1c tests sold by MedPro representatives.

“We’re thrilled to partner with PTS Diagnostics and believe that the certified accuracy, precision, and speed of their solutions will be a value add for physician offices, pharmacies, walk-in clinics, and more,” said Manny Losada, President of MedPro Healthcare Sales Solutions. Together we hope to positively impact at-risk populations at the point of care.

This announcement comes on the heels of PTS Diagnostics’ recent A1CNow+ Controls™ product launch and it precedes future 2020 product announcements.

To learn more about PTS Diagnostics or to connect with a sales representative, email: customerservice@ptsdiagnostics.com, or call 877-870-5610.

About PTS Diagnostics

Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

About MedPro Healthcare Sales Solutions

Med-Pro Associates is a nationwide independent rep group specializing in representing leading manufacturers across the country who sell their products both through distribution and direct to the hospital, long term care, physician, dental and veterinary markets.

Press Contact

Ryan Simpson, Marketing Communications
317-870-5610 –  rsimpson@ptsdiagnostics.com

PTS Diagnostics Announces A1CNow+ Controls™

PTS Diagnostics Announces A1CNow+ Controls™ 

Refrigerated storage up to 8 months, initially available in U.S., Europe

WHITESTOWN, Ind. (March 23, 2020) – PTS Diagnostics, a U.S.-based manufacturer of point-of-care medical testing devices announced today that they are launching A1CNow+ Controls for the A1CNow®+ Test System.

Initially available in the United States, European Union, and the United Kingdom, A1CNow+ Controls can be stored frozen for up to three years, refrigerated for eight months, or at room temperature for seven days. Intended to ensure accurate A1C results, the solution comes with two levels, each in a dropper style vial and can be successfully run in minutes.

“PTS Diagnostics-branded controls ensure that our customers have access to a high-quality solution that meets our stringent regulatory guidelines,” said Mark Duncan, Director, Global Product Management. “We are excited to provide benefits such as easy-to-use dropper style vials and extended shelf life.”

For additional information about the product, reference the A1CNow+ Controls webpage. Please call customer service at 317-870-5610 (direct) or 877-870-5610 (toll-free US only) with any questions. Connect with your local distribution partner if you are interested in purchasing A1CNow+ Controls or any other product. Find them via PTS Diagnostics Distributors.

About PTS Diagnostics

Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

Press Contact

Ryan Simpson, Distribution Marketing
317-870-5610 –  rsimpson@ptsdiagnostics.com